Dx Deals: Fulgent Genetics Scores Two Laboratories in a Single Deal
It is acquiring Bako Diagnostics and StrataDx for a combined $55.5 million

Subscribe to view Essential
Start a Free Trial for immediate access to this article
It is acquiring Bako Diagnostics and StrataDx for a combined $55.5 million

Start a Free Trial for immediate access to this article